{"id":1738,"date":"2018-12-16T06:28:23","date_gmt":"2018-12-16T06:28:23","guid":{"rendered":"https:\/\/crigroup.com\/?post_type=case-study&#038;p=1738"},"modified":"2022-03-30T08:40:13","modified_gmt":"2022-03-30T08:40:13","slug":"pharma-due-diligence","status":"publish","type":"case-study","link":"https:\/\/crigroup.com\/ar\/case-study\/pharma-due-diligence\/","title":{"rendered":"Major Pharma conducts due diligence investigation: lessons learned"},"content":{"rendered":"<p><strong>UNETHICAL PRACTICES, CONFLICT OF INTEREST, BRIBERY, AND CORRUPTION DISCOVERED AMONG A RANGE OF EMPLOYEES <\/strong><em>AT MAJOR PHARMA COMPANY, EVEN THE CFO WAS ON THE TAKE &#8211;<\/em><\/p>\n<p>A major pharmaceutical company engaged CRI Group to conduct an integrity due diligence and conflict of interest investigation. The focus of the action was to uncover unethical practices, including bribery and corruption, by senior employees. The client\u2019s corporate security department had received conflict of interest complaints that reportedly involved a range of employees, from sales personnel on up to the chief financial officer (CFO).<\/p>\n<p>This ebook examines the following:<\/p>\n<ul>\n<li>Pharmaceutical industry<\/li>\n<li>Real life case<\/li>\n<li>Lack of internal controls<\/li>\n<li>Implications<\/li>\n<li>When to open a due diligence investigation<\/li>\n<\/ul>\n<h3>Download your <a href=\"https:\/\/crigroup.com\/download-a-file\/?dynamictext_945=https:\/\/2506761.fs1.hubspotusercontent-na1.net\/hubfs\/2506761\/PDF%20library\/Pharma%20case%20studies%20uncovered%20DUE%20DILIGENCE%20lessons%20learned_%20by%20CRI.pdf\">FREE ebook here<\/a>!<\/h3>\n<p><a href=\"https:\/\/crigroup.com\/download-a-file\/?dynamictext_945=https:\/\/crigroup.com\/wp-content\/uploads\/2021\/Pharma-case-studies-uncovered-due-diligence-lessons-learned.pdf\"><img decoding=\"async\" class=\"alignleft size-full wp-image-8517\" src=\"https:\/\/crigroup.com\/wp-content\/uploads\/2020\/09\/PHARMA3.jpg\" alt=\"\" width=\"300\" height=\"200\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong><span data-preserver-spaces=\"true\">Who is CRI<\/span><\/strong><span data-preserver-spaces=\"true\">\u00ae<\/span><strong><span data-preserver-spaces=\"true\">\u00a0Group?<\/span><\/strong><\/p>\n<p><span data-preserver-spaces=\"true\">Based in London, CRI\u00ae Group works with companies across the Americas, Europe, Africa, Middle East and Asia-Pacific as a one-stop international\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=b733ad82-0e55-4917-bb02-011bb79f838d&amp;placement_guid=250fb2a7-fa34-4014-a23e-a19ec41aee8a&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Four-solutions%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Risk Management<\/span><\/a><span data-preserver-spaces=\"true\">,\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=4ec58284-73b3-46f5-a11f-d9dcc6b8e17e&amp;placement_guid=f957ed6c-edc3-4286-ac30-f33caa6f81f9&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Femployee-background-checks%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Employee Background Screening<\/span><\/a><span data-preserver-spaces=\"true\">,\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/crigroup.com\/business-intelligence\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Business Intelligence<\/span><\/a><span data-preserver-spaces=\"true\">,\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=13966f36-e2fa-4f6b-afeb-5a9004f47f91&amp;placement_guid=67fe51fd-e7a3-4fe3-814a-c8c713aa06e5&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Fthird-party-risk-management%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">TPRM<\/span><\/a><span data-preserver-spaces=\"true\">,\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=b8a8c479-0172-4651-bdd7-06d3a3e1b42b&amp;placement_guid=26b207ed-54ef-48d8-a2eb-d0931ca99b39&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Fdue-diligence%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Due Diligence<\/span><\/a><span data-preserver-spaces=\"true\">,\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=e0e860b5-1822-40b5-a34c-d0a8782d97c8&amp;placement_guid=46f09df8-0452-4582-a178-75554e2c10bc&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Fcompliance-solutions%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Compliance Solutions<\/span><\/a><span data-preserver-spaces=\"true\">\u00a0and other professional\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=186c5f76-08e9-452a-b6c7-53c143e3a42e&amp;placement_guid=da1251cb-798d-4e81-a03a-6484600d1cf1&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fcrigroup.com%2Finvestigative-solutions%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Investigative Research<\/span><\/a><span data-preserver-spaces=\"true\">\u00a0solutions provider. We have the largest proprietary network of background-screening analysts and investigators across the Middle East and Asia. Our global presence ensures that no matter how international your operations are we have the network needed to provide you with all you need, wherever you happen to be. CRI\u00ae Group also holds\u00a0<\/span><strong><span data-preserver-spaces=\"true\">BS 102000:2013<\/span><\/strong><span data-preserver-spaces=\"true\">\u00a0and\u00a0<\/span><strong><span data-preserver-spaces=\"true\">BS 7858:2012 Certifications<\/span><\/strong><span data-preserver-spaces=\"true\">, is an HRO certified provider and partner with Oracle.<\/span><\/p>\n<p><span data-preserver-spaces=\"true\">In 2016, CRI\u00ae Group launched\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Anti-Bribery Anti-Corruption (ABAC\u00ae) Center of Excellence<\/span><\/a><span data-preserver-spaces=\"true\">\u00a0\u2013 an independent certification body that provides education and certification services for individuals and organisations on a wide range of disciplines and ISO standards, including\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/iso-31000-risk-management\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">ISO 31000:2018 Risk Management- Guidelines<\/span><\/a><span data-preserver-spaces=\"true\">;\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/iso-37000-governance-of-organisations\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">ISO 37000:2021 Governance of Organisations<\/span><\/a><span data-preserver-spaces=\"true\">;\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/iso-37002-whistleblowing-certification\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">ISO 37002:2021 Whistleblowing Management System<\/span><\/a><span data-preserver-spaces=\"true\">;\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/iso-37301-certification\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">ISO 37301:2021 (formerly ISO 19600) Compliance Management system (CMS)<\/span><\/a><span data-preserver-spaces=\"true\">;\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/aml-training\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Anti-Money Laundering (AML)<\/span><\/a><span data-preserver-spaces=\"true\">; and\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/abacgroup.com\/iso-37001-anti-bribery-certification\/\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">ISO 37001:2016 Anti-Bribery Management Systems ABMS<\/span><\/a><span data-preserver-spaces=\"true\">. ABAC\u00ae offers a complete suite of solutions designed to help organisations mitigate the internal and external risks associated with operating in multi-jurisdiction and multi-cultural environments while assisting in developing frameworks for strategic compliance programs.\u00a0<\/span><a class=\"editor-rtfLink\" href=\"https:\/\/cta-service-cms2.hubspot.com\/ctas\/v2\/public\/cs\/preview\/click?cta_guid=2636d9bd-18de-499a-87a0-d62c4dd9c096&amp;placement_guid=c423f6be-c336-4a5b-834b-d1bccfd03ad6&amp;portal_id=2506761&amp;redirectUrl=https%3A%2F%2Fabacgroup.com%2Fcontact%2F\" target=\"_blank\" rel=\"noopener\"><span data-preserver-spaces=\"true\">Contact ABAC\u00ae for more<\/span><\/a><span data-preserver-spaces=\"true\">\u00a0on ISO Certification and training.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"featured_media":8506,"template":"","categories":[24,21,12,13,36],"tags":[33,35,70,132,133,134],"class_list":["post-1738","case-study","type-case-study","status-publish","has-post-thumbnail","hentry","category-all-regions","category-background-investigation","category-due-diligence","category-employee-background-check","category-pharmaceutical-healthcare","tag-bribery","tag-corruption","tag-due-diligence","tag-pharma","tag-risk-assessment","tag-unethical-practices"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v16.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"Major Pharma conducts due diligence investigation and conflict of interest investigation case study: uncover unethical practices.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/crigroup.com\/ar\/case-study\/pharma-due-diligence\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Major Pharma conducts due diligence investigation\" \/>\n<meta property=\"og:description\" content=\"Major Pharma conducts due diligence investigation and conflict of interest investigation case study: uncover unethical practices.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/crigroup.com\/ar\/case-study\/pharma-due-diligence\/\" \/>\n<meta property=\"og:site_name\" content=\"Corporate Research &amp; Investigations | CRI Group&trade;\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/crigroup\/\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-30T08:40:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/crigroup.com\/wp-content\/uploads\/2018\/12\/PHARMA1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"383\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@crigroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/crigroup.com\/#organization\",\"name\":\"CRI Group\\u2122\",\"url\":\"https:\/\/crigroup.com\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/crigroup\/\",\"https:\/\/www.linkedin.com\/company\/corporateresearchandinvestigations\/\",\"https:\/\/www.youtube.com\/channel\/UCn-EXXdew6XIApQm0kyGPMw\/\",\"https:\/\/twitter.com\/crigroup\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/crigroup.com\/#logo\",\"inLanguage\":\"ar\",\"url\":\"https:\/\/crigroup.com\/wp-content\/uploads\/2022\/04\/CRI-Group-Copy.jpg\",\"contentUrl\":\"https:\/\/crigroup.com\/wp-content\/uploads\/2022\/04\/CRI-Group-Copy.jpg\",\"width\":1920,\"height\":796,\"caption\":\"CRI Group\\u2122\"},\"image\":{\"@id\":\"https:\/\/crigroup.com\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/crigroup.com\/#website\",\"url\":\"https:\/\/crigroup.com\/\",\"name\":\"Corporate Research &amp; Investigations | CRI Group&trade;\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/crigroup.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/crigroup.com\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ar\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/#primaryimage\",\"inLanguage\":\"ar\",\"url\":\"https:\/\/crigroup.com\/wp-content\/uploads\/2018\/12\/PHARMA1.jpg\",\"contentUrl\":\"https:\/\/crigroup.com\/wp-content\/uploads\/2018\/12\/PHARMA1.jpg\",\"width\":383,\"height\":200,\"caption\":\"Major Pharma conducts due diligence investigation and the lessons learned\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/#webpage\",\"url\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/\",\"name\":\"Major Pharma conducts due diligence investigation\",\"isPartOf\":{\"@id\":\"https:\/\/crigroup.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/#primaryimage\"},\"datePublished\":\"2018-12-16T06:28:23+00:00\",\"dateModified\":\"2022-03-30T08:40:13+00:00\",\"description\":\"Major Pharma conducts due diligence investigation and conflict of interest investigation case study: uncover unethical practices.\",\"breadcrumb\":{\"@id\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/crigroup.com\/case-study\/pharma-due-diligence\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/crigroup.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Case Studies\",\"item\":\"https:\/\/crigroup.com\/case-study\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"All Solutions\",\"item\":\"https:\/\/crigroup.com\/all-solutions\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Anti-Bribery Anti-Corruption Solution\",\"item\":\"https:\/\/crigroup.com\/all-solutions\/anti-bribery-anti-corruption-solution\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Major Pharma conducts due diligence investigation: lessons learned\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/case-study\/1738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/case-study"}],"about":[{"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/types\/case-study"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/media\/8506"}],"wp:attachment":[{"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/media?parent=1738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/categories?post=1738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/crigroup.com\/ar\/wp-json\/wp\/v2\/tags?post=1738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}